Log on / register
Feedback | Support | My details
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration.
Hurley SF, Matthews JP, Guymer RH
Cost Eff Resour Alloc 2008, 6:12
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
Hurley SF, Matthews JP, Guymer RH
Cost Effectiveness and Resource Allocation 2008, 6:18 (11 September 2008)
[Full text] [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.